At a glance
ClinicalIndex Comparison RecordPhase 1Completed· 56 enrolled
Drug / intervention
Levodopa +2 moredrug
Likely dose
Levodopa 50 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Dose-finding Study for Levodopa, Carbidopa and ODM-104 Test Formulations After Repeated Administration in Healthy Males
In Brief
A Phase 1 clinical trial evaluating Levodopa, Carbidopa, and 1 other intervention for Healthy Volunteers. Completed, enrolled 56 participants across 1 site.
Detailed Summary
This is a phase I PK study in healthy males.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy Volunteers
CountriesGermany
Collaborators--
Timeline
Phase 1CompletedFinished
2017201820192020202120222023202420252026
First PostedFeb 2017
Enrollment StartFeb 2017
Primary CompletionJun 2017
TodayJul 2026
First PostedFeb 16, 2017
Enrollment StartFeb 21, 2017
Primary CompletionJun 9, 2017
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 9.4 years ago
Interventions
Levodopadrug
Levodopa 50 mg or 100 mg or 150 mg
Carbidopadrug
Carbidopa 12.5 mg or 25 mg or 65 mg
ODM-104drug
ODM-104 50 mg or 100 mg